Evidence map›Paper›PMID 37627695›Full record

ArticleAntibiotics (Basel, Switzerland)2023

A High-Performance Antibacterial Nanostructured ZnO Microfluidic Device for Controlled Bacterial Lysis and DNA Release.

Yvonni Xesfyngi, Maria Georgoutsou-Spyridonos, Abinash Tripathy, Athanasios Milionis, Dimos Poulikakos, Dimitrios C Mastellos, Angeliki Tserepi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Yvonni XesfyngiInstitute of Nanoscience and Nanotechnology, National Center for Scientific Research (NCSR) "Demokritos", Patr. Gregoriou E' and 27 Neapoleos Str., 15341 Aghia Paraskevi, Greece.
Maria Georgoutsou-SpyridonosInstitute of Nanoscience and Nanotechnology, National Center for Scientific Research (NCSR) "Demokritos", Patr. Gregoriou E' and 27 Neapoleos Str., 15341 Aghia Paraskevi, Greece.
Abinash TripathyLaboratory of Thermodynamics in Emerging Technologies, Department of Mechanical and Process Engineering, ETH Zurich, 8092 Zurich, Switzerland.ORCID 0000-0003-3546-2806
Athanasios MilionisLaboratory of Thermodynamics in Emerging Technologies, Department of Mechanical and Process Engineering, ETH Zurich, 8092 Zurich, Switzerland.
Dimos PoulikakosLaboratory of Thermodynamics in Emerging Technologies, Department of Mechanical and Process Engineering, ETH Zurich, 8092 Zurich, Switzerland.
Dimitrios C MastellosInstitute of Nuclear & Radiological Sciences and Technology, Energy & Safety, National Center for Scientific Research (NCSR) "Demokritos", Patr. Gregoriou E' and 27 Neapoleos Str., 15341 Aghia Paraskevi, Greece.
Angeliki TserepiInstitute of Nanoscience and Nanotechnology, National Center for Scientific Research (NCSR) "Demokritos", Patr. Gregoriou E' and 27 Neapoleos Str., 15341 Aghia Paraskevi, Greece.
National Centre of Scientific Research "Demokritos" · GRETH Zurich · CH

Funding

Operational Programme "Competitiveness, Entrepreneurship and Innovation" (NSRF 2014-2020) and co-financed by Greece and the European Union (European Regional Development Fund) MIS 5002567
6 · The paper itself

Abstract

In this work, the antibacterial properties of nanostructured zinc oxide (ZnO) surfaces are explored by incorporating them as walls in a simple-to-fabricate microchannel device. Bacterial cell lysis is demonstrated and quantified in such a device, which functions due to the action of its nanostructured ZnO surfaces in contact with the working fluid. To shed light on the mechanism responsible for lysis,

Indexed as

antibacterial surfacesbacterial DNAbacterial lysisnanostructured ZnOreactive oxygen speciesstatic microfluidic chip

Identifiers

PMID37627695
PMCPMC10451374
OpenAlexW4385481345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.